The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PROs) in locally advanced cervical cancer (LACC): Insights from the OUTBACK trial.
 
Rebecca Mercieca-Bebber
No Relationships to Disclose
 
Elizabeth Barnes
No Relationships to Disclose
 
Kathleen Moore
Leadership - GOG Partners; NRG Oncology (Inst)
Honoraria - Astellas Medivation; Clinical Education Alliance; Haymarket Medical Education; IDEOlogy Health; Medscape; The Clearity Foundation
Consulting or Advisory Role - AADi; Abbvie; ADC Therapeutics; AstraZeneca; BioNTech SE; Blueprint Medicines (Inst); Bristol Myers Squibb Foundation; Caris Life Sciences; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo Europe GmbH; Duality Biologics (Inst); Eisai; Elucida Oncology; Exelixis; Genentech/Roche; GlaxoSmithKline/Tesaro (Inst); immunocore; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Loxo/Lilly; Merck; Mersana (Inst); Novocure; ProfoundBio; Regeneron; Roche; Sanofi/Aventis; Schrodinger (Inst); seagen; T knife; Takeda Science Foundation; Tango Therapeutics; Third Arc; Tubulis GmbH; Verastem/Pharmacyclics; Xencor; zentalis; zymeworks
Research Funding - Amgen (Inst); artios (Inst); AstraZeneca (Inst); Daiichi Sankyo/Lilly (Inst); Immunocore (Inst); Immunogen (Inst); Merck (Inst); Regeneron (Inst); Verastem (Inst)
Other Relationship - GOG Partners (Inst)
 
Yeh Chen Lee
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Speakers' Bureau - AstraZeneca; Eisai
Research Funding - BeiGene (Inst)
 
Kailash Narayan
No Relationships to Disclose
 
Pearly Khaw
Honoraria - MSD (Inst)
 
Martin Buck
No Relationships to Disclose
 
Anthony Fyles
No Relationships to Disclose
 
Susan Brooks
No Relationships to Disclose
 
Jayanthi Lea
Consulting or Advisory Role - AstraZeneca
Research Funding - Merck
 
Ashley Stuckey
No Relationships to Disclose
 
Thomas Lad
No Relationships to Disclose
 
Christine Holschneider
No Relationships to Disclose
 
Nicola Spirtos
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); NRG/GOG FOUNDATION (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Application No. PCT/US 2019/19465 CANNABIS BASED THERAPEUTIC AND METHOD OF USE Application No.; John Wiley and Sons Editor 12th Edition Bonney's Gynaecological Surgery; Title Country Status Filed Date Application No. Patent Ref. No.199236-701611/EP Title: CANNABIS BASED THERAPEUTIC AND METHOD OF USE Country: European Patent Status: Published 2/25/2019 19710540.6 Patent Ref. No.199236-701691/PCT-BR Title: CANNA; US Patent 0024098766 Compounds Cannabidiol and Flavanones 63/047550 (7-1-20) 63/055458 (7-23-20)
 
Leslie Boyd
Consulting or Advisory Role - AstraZeneca (Inst)
 
William Small
Honoraria - Carl Zeiss Meditec
Consulting or Advisory Role - GlaxoSmithKline; Novocure
Travel, Accommodations, Expenses - Carl Zeiss Meditec
 
Bradley Monk
Honoraria - Abbvie; AstraZeneca; BioNTech SE; Corcept Therapeutics; DSI; Eisai; Genmab; Genmab/Seagen; GlaxoSmithKline; GOG Foundation; Immunogen; Incyte; Karyopharm Therapeutics; Lilly; Merck; Mersana; Mural; Myriad Genetics; Natera; Novartis; Novocure; Onco4; Panavance Therapeutics; Pharma&; ProfoundBio; Regeneron; Roche/Genentech; Sutro Biopharma; Tubulis GmbH; Verastem; Zentalis; Zymeworks
Consulting or Advisory Role - Abbvie; Alkermes; AstraZeneca; BioNTech SE; Corcept Therapeutics; DSI; Eisai; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Incyte; Karyopharm Therapeutics; Lilly; Merck; Mersana; Myriad Pharmaceuticals; Natera; Novartis; Novocure; OncoC4; Panavance Therapeutics; Pharma&; ProfoundBio; Regeneron; Roche/Genentech; Sutro Biopharma; Tubulis GmbH; Verastem; Zentalis; Zymeworks
Speakers' Bureau - AstraZeneca; Eisai; Immunogen/Abbvie; Lilly; Merck; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)
 
Martin Stockler
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Tilray (Inst)
 
Madeleine King
No Relationships to Disclose
 
Linda Mileshkin
Honoraria - GlaxoSmithKline; The Limbic
Research Funding - BeiGene (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - Roche